Aromatherapy to Help Chemotherapy-Related Neuropathy in Breast Cancer Patients
Official title: Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN) in Patients Receiving Taxane Therapy for Breast Cancer.
Run by Centre Hospitalier de Colmar · NCT07779135 · Data updated 2026-11-12
This study tests whether an essential oil blend applied to the skin can help reduce painful neuropathy in breast cancer patients treated with paclitaxel.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | Centre Hospitalier de Colmar Academic / other |
| Drugs / interventions | Chemotherapy |
| Locations | 1 site (Colmar) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | May 15, 2027 |
| Study ends | September 15, 2027 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07779135 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult women with breast cancer who have painful CIN related to paclitaxel and have not achieved relief with standard treatments or cannot tolerate them.
✕Probably not a fit
Patients with non-painful CIN, those without paclitaxel-related neuropathy, or those who cannot complete questionnaires may not see benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study describes how a topical essential oil blend is used to address chemotherapy-induced neuropathy in breast cancer patients who have received paclitaxel. Participants are women with CIN who have insufficient relief from conventional medicines and consent to data use. The analysis will focus on pain, sensory changes, and functional impairments reported by patients, using questionnaires. No intervention beyond the aromatherapy blend is described, and results will help understand potential real-world effects and safety. The study is led by Centre Hospitalier de Colmar at Hôpitaux Civils de Colmar in Colmar, France.
Why it matters
Potential benefit: If the blend shows benefit, patients may experience reduced pain and better function related to CIN.
How similar studies have gone: Previous research on aromatherapy for CIN has shown mixed results; this observational description seeks to characterize real-world use and potential signals.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients with breast cancer * who have painful or bothersome CIN * occurring in the context of paclitaxel treatment (during or after treatment) * for whom conventional drug treatments provide insufficient relief (or are poorly tolerated or refused). * Age ≥ 18 years * Who, after receiving information, do not object to the use of their data for the purposes of this research Exclusion Criteria: * Pre-existing neuropathy (e.g., due to diabetes) * Known allergy to an essential oil or a component of essential oils (e.g., linalool) * Presence of wounds on the affected areas * Refusal to use aromatherapy * Inability to complete the questionnaires
Where it's running
-
Hôpitaux Civils de Colmar
Colmar, France Recruiting
Study contacts
- Principal investigator: Karine Demesmay — Hopitaux Civils de Colmar
- Study coordinator: Karine Demesmay
- Email: karine.demesmay@ch-colmar.fr
- Phone: +33 3 89 12 42 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.